LIBERTY PARTNERS GROUP, LLC

Lobbying for TELIX PHARMACEUTICALS US · Diagnostic radiopharmaceutical providing precision medicine to patients in the U.S.

Filing 1st Quarter - Report

1st Quarter (Jan 1 - Mar 31) 2026 · Indiana · House · Senate · $50,000.00 income · posted Apr 17, 2026

Lobbying activity 3

Health Issues

Medicare reimbursement, working with Congress on legislation relating to the early detection and treatment of deadly diseases.

Medicare/Medicaid

Medicare reimbursement, working with Congress on legislation relating to the early detection and treatment of deadly diseases.

Medical/Disease Research/Clinical Labs

Medicare reimbursement, working with Congress on legislation relating to the early detection and treatment of deadly diseases.

Source: federal Lobbying Disclosure Act filing. Bills are parsed from the activity descriptions.